INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,673,889 | -20.0% | 242,691 | +3.2% | 0.04% | -15.1% |
| Q2 2023 | $9,592,638 | +49.8% | 235,229 | +36.9% | 0.05% | +43.2% |
| Q1 2023 | $6,405,000 | -1.3% | 171,879 | -8.3% | 0.04% | -7.5% |
| Q4 2022 | $6,492,000 | -40.5% | 187,365 | -3.9% | 0.04% | -43.7% |
| Q3 2022 | $10,915,000 | +6.0% | 195,063 | -2.0% | 0.07% | +9.2% |
| Q2 2022 | $10,301,000 | -38.8% | 199,032 | -14.0% | 0.06% | -24.4% |
| Q1 2022 | $16,824,000 | -37.3% | 231,517 | +4.6% | 0.09% | -27.1% |
| Q4 2021 | $26,843,000 | -13.5% | 221,404 | -4.3% | 0.12% | -15.7% |
| Q3 2021 | $31,030,000 | -28.0% | 231,312 | -13.1% | 0.14% | -24.3% |
| Q2 2021 | $43,087,000 | – | 266,123 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |